|
Derivation
|
HPAC is a pancreatic adenocarcinoma epithelial cell line derived in 1985 from a nude mouse xenograft of a primary tumor removed from the head of the pancreas of a woman with moderate to well differentiated pancreatic adenocarcinoma of ductal origin.
|
|
Clinical Data
|
HPAC is a pancreatic adenocarcinoma epithelial cell line derived in 1985 from a nude mouse xenograft of a primary tumor removed from the head of the pancreas of a woman with moderate to well differentiated pancreatic adenocarcinoma of ductal origin.
|
|
Receptor Expression
|
epidermal growth factor (EGF), expressed glucocorticoid, expressed epidermal growth factor (EGF); glucocorticoid
|
|
Genes Expressed
|
HPAC cells are positive for keratin and negative for vimentin and chromogranin A.
|
|
Effects
|
Yes, the cells form tumors in athymic nude mice at the site of inoculation which are histologically similar to the tumor of origin Yes, the cells have a colony forming efficiency of 64% on plastic and 3.2% in agarose.
|
|
Comments
|
HPAC proliferation is stimulated by insulin, insulin-like growth factor I (IGF-I), epidermal growth factor (EGF), and transforming growth factor alpha (TGF alpha). Cell growth is suppressed by dexamethasone and other glucocorticoids. Crude HPAC cell exacts contained significant concentrations of tumor-associated antigens CEA, CA 125, and CA 19-9. In culture, HPAC cells form monolayers of morphologically heterogenous polar epithelial cells. HPAC is the first reported human pancreatic adenocarcinoma cell line to express a functional glucocorticoid receptor.
|